OncoTAb
Lexington, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
OncoTAb is a US-based biotechnology company founded in 2012, focused on developing diagnostic and therapeutic solutions for cancer. The company's core technology targets a specific form of the MUC1 protein (tMUC1) associated with epithelial cancers. Its lead product, Agkura Personal Score, is a blood test designed to aid in the early detection of breast cancer, particularly for women with dense breast tissue where mammography is less effective.
Genetics & Genomics